Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC
Clinical trial NCT04476797 · TERMINATED
Trial details
- NCT number
- NCT04476797
- Sponsor
- Galera Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-18
- Primary completion
- 2023-11-28
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.